Evaluation of novel second-generation RSV and influenza rapid tests at the point of care

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 3, 2015, Pages 171-176

  Tuttle, Ryan ^a   Weick, Anja ^a   Schwarz, Wiebke Sabrina ^a   Chen, Xi ^a   Obermeier, Patrick ^a   Seeber, Lea ^a   Tief, Franziska ^a   Muehlhans, Susann ^a   Karsch, Katharina ^a   Peiser, Christian ^a   Duwe, Susanne ^b   Schweiger, Brunhilde ^b   Rath, Barbara ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Influenza like illness; Minimally invasive testing; Point of care diagnostics; Rapid testing; Respiratory syncytial virus

Indexed keywords

AGE; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; INFLUENZA A; INFLUENZA B; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL SWAB; NONHUMAN; NOSE SMEAR; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RAPID TEST; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND GENERATION INFLUENZA RAPID TEST; SECOND GENERATION RESPIRATORY SYNCYTIAL VIRUS RAPID TEST; SENSITIVITY AND SPECIFICITY; SMEAR; TOTAL QUALITY MANAGEMENT; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD; ADOLESCENT; DIAGNOSTIC TEST; EVALUATION STUDY; HOSPITAL INFORMATION SYSTEM; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; NASOPHARYNX; NEWBORN; PROCEDURES; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TIME; VIROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; NASOPHARYNX; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84925217497     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.11.013     Document Type: Article

References (42)

1. Bawage S.S., Tiwari P.M., Pillai S., Dennis V., Singh S.R. Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. Adv Virol 2013, 2013:595768.
2. Bonner A.B., Monroe K.W., Talley L.I., Klasner A.E., Kimberlin D.W. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003, 112:363-367.
3. Bont L., Versteegh J., Swelsen W.T., Heijnen C.J., Kavelaars A., Brus F., et al. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity. Pediatr Res 2002, 52:363-367.
4. Bossuyt P.M., Reitsma J.B. The STARD initiative. Lancet 2003, 361(9351):71.
5. Bracht M., Basevitz D., Cranis M., Paulley R. Impact of respiratory syncytial virus: the nurse's perspective. Drugs R&D 2011, 11:215-226.
6. Casiano-Colon A.E., Hulbert B.B., Mayer T.K., Walsh E.E., Falsey A.R. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 2003, 28:169-174.
7. Centers for Disease Control and Prevention (CDC) Respiratory syncytial virus infection (RSV): infection and incidence 2010, vol. 2014. CDC, [Date accessed: May 30, 2014. URL: http://www.cdc.gov/rsv/about/infection.html].
8. Chen X., Pouran Yousef K., Duwe S., Karsch K., Grover S., Wahlisch S., et al. Quantitative influenza follow-up testing (QIFT)-a novel biomarker for the monitoring of disease activity at the point-of-care. PLoS One 2014, 9(3):e92500.
9. CMDA Proposed reclassification of the rapid influenza detection tests 2013,30. U.S. Food and Drug Administration (FDA), Gaithersburg, Maryland, [URL: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM356185.pdf].
10. Dunn J., Obuekwe J., Baun T., Rogers J., Patel T., Snow L. Prompt detection of influenza A and B viruses using the BD Veritor System Flu A+B, Quidel(R) Sofia(R) Influenza A+B FIA, and Alere BinaxNOW(R) Influenza A&B compared to real-time reverse transcription-polymerase chain reaction (RT-PCR). Diagn Microbiol Infect Dis 2014, 79:10-13.
11. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352:1749-1759.
12. Fiore A.E., Fry A., Shay D., Gubareva L., Bresee J.S., Uyeki T.M. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(1):1-24.
13. Geis S., Prifert C., Weissbrich B., Lehners N., Egerer G., Eisenbach C., et al. Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany. J Clin Microbiol 2013, 51:155-162.
14. Geller R., Andino R., Frydman J. Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. PLoS One 2013, 8(2):e56762.
15. Ginocchio C.C., McAdam A.J. Current best practices for respiratory virus testing. J Clin Microbiol 2011, 49:S44-S48.
16. Ginocchio C.C., Swierkosz E., McAdam A.J., Marcon M., Storch G.A., Valsamakis A., et al. Multicenter study of clinical performance of the 3M Rapid Detection RSV test. J Clin Microbiol 2010, 48:2337-2343.
17. Gomez R.S., Mora J.E., Cortes C.M., Riedel C.A., Ferres M., Bueno S.M., et al. Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies. J Med Virol 2014, 86(7):1256-1266.
18. Hazelton B., Nedeljkovic G., Ratnamohan V.M., Dwyer D.E., Kok J. Evaluation of the Sofia Influenza A+B fluorescent immunoassay for the rapid diagnosis of influenza A and B. J Med Virol 2015, 87(1):35-38.
19. Heikkinen T., Marttila J., Salmi A.A., Ruuskanen O. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 2002, 40:4337-4339.
20. Henrickson K.J., Hall C.B. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007, 26:S36-S40.
21. Hurwitz J.L. Respiratory syncytial virus vaccine development. Expert Rev Vaccines 2011, 10:1415-1433.
22. Kimpen J.L. Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 2002, 3(Suppl. 1):S40-S45.
23. Liolios L., Jenney A., Spelman D., Kotsimbos T., Catton M., Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J Clin Microbiol 2001, 39:2779-2783.
24. MarketWired Quidel Receives FDA Clearance for Its Sofia® RSV Fluorescent Immunoassay (FIA) 2013, MarketWired. marketwired.com, [Date accessed: March 30, 2014. URL: http://www.marketwired.com/press-release/quidel-receives-fda-clearance-for-its-sofiar-rsv-fluorescent-immunoassay-fia-nasdaq-qdel-1822255.htm].
25. Meissner H.C. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003, 22:S40-S44. [discussion S44-45].
26. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
27. Papenburg J., Buckeridge D.L., De Serres G., Boivin G. Host and viral factors affecting clinical performance of a rapid diagnostic test for respiratory syncytial virus in hospitalized children. J Pediatr 2013, 163:911-913.
28. Prendergast C., Papenburg J. Rapid antigen-based testing for respiratory syncytial virus: moving diagnostics from bench to bedside?. Future Microbiol 2013, 8:435-444.
29. Principi N., Esposito S. Antigen-based assays for the identification of influenza virus and respiratory syncytial virus: why and how to use them in pediatric practice. Clin Lab Med 2009, 29:649-660.
30. Quidel C. SOFIA RSV FIA package insert 2013, Quidel Corp., San Diego, CA.
31. Rath B., Tief F., Obermeier P., Tuerk E., Karsch K., Muehlhans S., et al. Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing. J Clin Virol 2012, 55:329-333.
32. Rath B., von Kleist M., Tief F., Karsch K., Tuerk E., Muehlhans S., et al. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses. Pediatr Infect Dis J 2012, 31:899-905.
33. Reiche J., Schweiger B. Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol 2009, 47:1800-1810.
34. Robert Koch Institute Bericht zur Epidemiologie der Influenza in Deutschland Saison 2010/11 2011, Robert Koch Institute (RKI), [https://influenza.rki.de/Saisonberichte/].
35. Ruest A., Michaud S., Deslandes S., Frost E.H. Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 2003, 41:3487-3493.
36. Sung R.Y., Chan P.K., Choi K.C., Yeung A.C., Li A.M., Tang J.W., et al. Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol 2008, 46:3073-3076.
37. Szabo S.M., Gooch K.L., Bibby M.M., Vo P.G., Mitchell I., Bradt P., et al. The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection. Paediatr Respir Rev 2013, 13(Suppl. 2):S1-S8.
38. Tayyari F., Hegele R.G. Identifying targets in the hunt for effective respiratory syncytial virus interventions. Expert Rev Respir Med 2012, 6:215-222.
39. UNICEF/WHO Pneumonia: the forgotten killer of children 2006, vol. 40. World Health Organization, Geneva.
40. Walsh P., Overmyer C.L., Pham K., Michaelson S., Gofman L., DeSalvia L., et al. Comparison of respiratory virus detection rates for infants and toddlers by use of flocked swabs, saline aspirates, and saline aspirates mixed in universal transport medium for room temperature storage and shipping. J Clin Microbiol 2008, 46:2374-2376.
41. Walsh P., Overmyer C., Hancock C., Heffner J., Walker N., Nguyen T., et al. Is the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative?. Emerg Med J 2013.
42. World Health Organization (WHO) FluNet 2014, WHO, [Date accessed: June 15, 2014. URL: http://www.who.int/influenza/gisrs_laboratory/flunet/en/].